PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $356,000 | +21.1% | 68,940 | -10.1% | 0.00% | – |
| Q2 2021 | $294,000 | +40.7% | 76,683 | -5.9% | 0.00% | – |
| Q1 2021 | $209,000 | -7.9% | 81,471 | -10.5% | 0.00% | – |
| Q4 2020 | $227,000 | +39.3% | 90,995 | +15.2% | 0.00% | – |
| Q3 2020 | $163,000 | -35.6% | 78,967 | -3.3% | 0.00% | – |
| Q2 2020 | $253,000 | +44.6% | 81,702 | +6.5% | 0.00% | – |
| Q1 2020 | $175,000 | +173.4% | 76,741 | +304.1% | 0.00% | – |
| Q3 2019 | $64,000 | +52.4% | 18,989 | +49.5% | 0.00% | – |
| Q1 2019 | $42,000 | -39.1% | 12,701 | -7.2% | 0.00% | – |
| Q2 2018 | $69,000 | -34.9% | 13,687 | -12.2% | 0.00% | – |
| Q1 2018 | $106,000 | +37.7% | 15,585 | +53.1% | 0.00% | – |
| Q4 2017 | $77,000 | -42.1% | 10,181 | -56.0% | 0.00% | – |
| Q3 2017 | $133,000 | +146.3% | 23,140 | +120.5% | 0.00% | – |
| Q2 2017 | $54,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |